ARCHIVES

Center Core Grants Picture Less Bleak; Competing Renewals To Receive 50% Of Recommended Increases

This article is from The Cancer Letter archive.

Vol. 06 No. 01 | January 4, 1980

Download PDF Visit The Full Archive

Related Articles

New Treatments And Quality of Life Study For Ovarian Cancer Described At SGO

March 26, 2004

ODAC Reviews Post-Marketing Studies for Eight Indications

February 21, 2003

In Brief: Tipping Resigns Forom ACS; Vaughan Joins UAB BMT Program; PCI Recruits Ball, Finn, Mirro

September 20, 1991

Committee Unblinds Phase III Zytiga Study

March 30, 2012

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995

Early Detection Network Completes Initial Funding From NCI.

June 2, 2000